Brevan Howard Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Brevan Howard Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,785	Closed	-$295K	–	1473
2024 Q1	$295K	Sell	18,785 -5,707	-23%	-$87.8K	﹤0.01%	664
2023 Q4	$395K	Buy	+24,492	New	+$312K	﹤0.01%	593

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Brevan Howard Capital Management's DCPH Position: Q2 2024 in Review

Brevan Howard Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 18,785 shares — an estimated $295K sold.

Brevan Howard Capital Management first reported a position in DCPH in Q4 2023 and held it in 2 quarters. The position peaked at $395K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Brevan Howard Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Brevan Howard Capital Management sold 18,785 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $295K.
Brevan Howard Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Brevan Howard Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $395K in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Brevan Howard Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.